Pharma Journalist -

The 6th annual conference will gather the growing freeze drying community, filled with industry thought leaders and principle scientists involved in: manufacturing, material sciences,…
Read More...

Eidos Therapeutics announced a $64.0 million Series B financing. Proceeds from the financing will be used to advance Eidos' small molecule product candidate, AG10, into Phase 2 clinical…
Read More...

AbbVie announced global resolution of all intellectual property-related litigation with Samsung Bioepis over its proposed biosimilar adalimumab product. Under the terms of the…
Read More...

Stemline Therapeutics announced that it has initiated its rolling submission of a Biologics License Application (BLA) for SL-401 to the U.S. Food and Drug Administration (FDA). SL-401…
Read More...

PhaseBio Pharmaceuticals announced that it has completed dosing in the first cohort of subjects in its Phase 1 clinical trial of PB2452 (formerly MEDI2452), a reversal agent for the…
Read More...

MyoKardia, Inc. announced that the first patient has been dosed in the company’s Phase 2 MAVERICK-HCM clinical trial. MAVERICK-HCM is the first clinical trial of mavacamten in…
Read More...

Agilent Technologies Inc. and Lasergen, Inc. (Lasergen) announced that they have signed a definitive agreement for Agilent to acquire the remaining shares of Lasergen, an emerging…
Read More...

Ferring Pharmaceuticals and Rebiotix Inc. announce that they have agreed to the acquisition of Rebiotix by Ferring. This acquisition brings together two innovative healthcare companies…
Read More...

Ubiquigent Limited announced that it has entered into a multi-year strategic R&D collaboration agreement with FORMA Therapeutics for the design and development of novel…
Read More...

Cardiva Medical announced that the company has received approval from the U.S. Food and Drug Administration (FDA) for an expanded indication of the VASCADE Vascular Closure System.…
Read More...